Clinical Trials Logo

Clinical Trial Summary

To examine the relations between sleep (nap transitions, sleep physiology), memory, and brain development longitudinally, the researchers will assess n=180 children (in order to acquire n=152 usable data sets) who are 36-54 months of age and habitual nappers at enrollment. In each wave, the researchers will assess memory, memory change over a nap and equivalent waking interval, sleep physiology of the nap, and brain structure and function (using Magnetic Resonance Imagining or MRI). Additionally, overnight sleep physiology will be assessed in all participants. Waves will take place approximately every 6 months. For all children, three waves will be collected. With these data, the researchers will address the following aims: - Examine neural markers that predict the sleep transition (Aim 1); - Examine changes in sleep-dependent memory processing (mnemonic discrimination) over both nap and overnight sleep intervals, across the sleep transition (Aim 2); - Examine changes in sleep microstructure in both nap and overnight sleep across the sleep transition (Aim 3) - Examine interrelations among brain, memory and sleep microstructure across the sleep transition (Aim 4)


Clinical Trial Description

Child participants will be recruited from databases maintained at each university (see Human Subjects). Initially, parent-report will determine whether the child qualifies as a habitual napper, which will later be confirmed by actigraphy. In each wave, participants will then complete 3 sessions, 3-7 days apart. The first two sessions will consist of nap or wake promotion (counter-balanced, separated by one week) and memory assessments. The third session will consist of a visit to the university for the MRI scan. All of the participants will also have overnight sleep and overnight sleep-dependent memory consolidation assessed on the evenings following the nap/wake sessions. An Actiwatch watch will be given to the participant at the beginning of the first wave. Instructions will be included describing how to put the watch on the child and that the watch should be worn as often as possible. Nap and wake sessions will begin 30 mins prior to the child's typical nap time (if habitual nappers) or approximately 12:30 pm (non-habitual nappers). First, children will complete the encoding and immediate retrieval phases of the mnemonic similarity task. Subsequently, children will either be nap- or wake-promoted. Polysomnography (PSG) will be applied in the nap condition, but timing will be equated in the wake condition. Thirty-minutes following wake (or approximately 3:30 pm for those in the wake group), children will complete the delayed retrieval phase of the mnemonic similarity task. Participants at both testing sites will also have overnight sleep and memory assessed after the nap and wake sessions. Experimenters will arrive at the participant's house about 30 mins prior the child's typical bedtime. The child will encode a new set of stimuli and complete the immediate retrieval phase of the mnemonic discrimination task. Subsequently, the child will be fitted with PSG. Parents are given instructions on placement of the PSG amplifier during the night and how to remove in the electrodes in the morning. Experimenters will return in the morning to retrieve the equipment and obtain the delayed retrieval phase of the mnemonic similarity task. Approximately 3-7 days after the second visit, children will complete the MRI session. The researchers will attempt to obtain MRI scans in the morning to avoid confounds with nap status. The Actiwatch will also be collected in this session. Children will then be fitted with the Fitbit to wear as often as possible between testing waves. These procedures will be repeated every 6 months for 2-3 waves. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06351098
Study type Interventional
Source University of Maryland, College Park
Contact
Status Recruiting
Phase Early Phase 1
Start date November 5, 2023
Completion date June 2028

See also
  Status Clinical Trial Phase
Completed NCT01007682 - Intrusive Reexperiencing: The Role of Working Memory Capacity and Thought Suppression N/A
Completed NCT04330677 - Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin Phase 1
Active, not recruiting NCT04392908 - Communication Memory of Cancer Diagnosis Within the Pediatric Triangle
Recruiting NCT04694534 - Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients N/A
Completed NCT01159652 - Hypnotic Medications and Memory: Effect of Drug Exposure During the Night Phase 4
Recruiting NCT04598945 - Acquisition and Retention of Motor Memories in Adults and Typically Developing Children N/A
Terminated NCT04021797 - Autonomic Mechanisms of Sleep-dependent Memory Consolidation N/A
Not yet recruiting NCT04103463 - Interactive Stepping Exercise on Memory N/A
Completed NCT04025255 - The Memory and Cognitive Performance Study N/A
Completed NCT06047899 - Influence of Luteolin for Two Weeks on Memory in Healthy Subjects N/A
Recruiting NCT04402294 - Individualized Closed Loop TMS for Working Memory Enhancement N/A
Completed NCT01126229 - Resveratrol for Improved Performance in the Elderly Phase 1
Completed NCT00913640 - Prospective Memory in Parkinson's Disease
Completed NCT03974399 - BDNF Levels After Bacopa N/A
Completed NCT01143194 - A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of Three Doses of the Dietary Supplement oréVida™ on Alertness, Attention and Concentration in Healthy Men and Women Phase 1
Completed NCT00454454 - Virtual Reality Helmet to Test for Problems With Memory N/A
Completed NCT00584324 - Depth of Anesthesia on Implicit Memory N/A
Completed NCT06074172 - The Effect of Cannabidiol in Learning and Memory of Adults Phase 2
Completed NCT03763409 - Losartan and Emotional Memory N/A
Completed NCT05907707 - Effects of Gamma-tACS on Memory and Sleep N/A